Histone Posttranslational Modifications in Schizophrenia

Adv Exp Med Biol. 2017:978:237-254. doi: 10.1007/978-3-319-53889-1_13.

Abstract

Schizophrenia is a complex neuropsychiatric disorder with high heritability; however, family and twin studies have indicated that environmental factors also play important roles in the etiology of disease. Environmental triggers exert their influence on behavior via epigenetic mechanisms. Epigenetic modifications, such as histone acetylation and methylation, as well as DNA methylation, can induce lasting changes in gene expression and have therefore been implicated in promoting the behavioral and neuronal behaviors that characterize this disorder. Importantly, because epigenetic processes are potentially reversible, they might serve as targets in the design of novel therapies in psychiatry. This chapter will review the current information regarding histone modifications in schizophrenia and the potential therapeutic relevance of such marks.

Keywords: CNS; Epigenetic; Psychiatric; Therapeutic.

Publication types

  • Review

MeSH terms

  • Acetylation
  • Amino Acid Sequence
  • Animals
  • Brain Chemistry
  • Disease Models, Animal
  • Electroconvulsive Therapy
  • Epigenesis, Genetic / genetics*
  • Histone Code / genetics*
  • Histone Code / physiology
  • Histone Deacetylase Inhibitors / therapeutic use
  • Humans
  • Lymphocytes / metabolism
  • Methylation
  • Mice
  • Nerve Tissue Proteins / genetics*
  • Nerve Tissue Proteins / metabolism
  • Phosphorylation
  • Protein Processing, Post-Translational / genetics*
  • Schizophrenia / drug therapy
  • Schizophrenia / genetics*
  • Schizophrenia / metabolism
  • Schizophrenia / therapy
  • Ubiquitination

Substances

  • Histone Deacetylase Inhibitors
  • Nerve Tissue Proteins